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Abstract
Background: Cancer burden among children and adolescents is largely unknown in Bangladesh. This study aims to
provide a comprehensive overview on childhood and adolescent cancers and to contribute to the future strategies
to deal with these diseases in Bangladesh.
Methods: Data on malignant neoplasms in patients aged less than 20 years diagnosed between 2001 and 2014
(N = 3143) in Bangladesh was collected by the National Institute of Cancer Research and Hospital and ASHIC
Foundation. The age pattern and distribution of cancer types were analysed and the incidence rates were
calculated.
Results: The age-standardised incidence rate was 7.8 per million person-years for children (0–14 years) in the last
time period (2011–2014). Retinoblastoma (25 %) and leukaemia (18 %) were the most common childhood cancers.
For adolescents (15–19 years), the age-specific incidence rate was 2.1 per million person-years in the same time
period. Most common adolescent cancers were malignant bone tumours (38 %), germ cell and gonadal tumours
(17 %), and epithelial tumours (16 %). There were more boys affected (M: F ratio 2.0 in children and 1.4 in
adolescents) than girls.
Conclusion: Cancer incidences were lower than expected most likely due to a low level of awareness about cancer
among clinicians and the population, inadequate access to health care, lack of diagnostic equipment and
incomplete recording of cases. Improvements on different levels should be made to get a better epidemiologic
insight and to detect cancer earlier resulting in a better outcome for affected children and adolescents.
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Background
Childhood cancers are neglected in developing countries,
even though approximately 84 % of the cancer cases under
15 years old occur in the low-income and middle-income
countries (LMICs) [1]. Because of decreased infant mor-
tality rates in developing countries resulting from better
management of infectious diseases and current population
growth, the number of childhood cancer is expected to
increase by 30 % by 2020 [2].
Due to the diversity and scarcity of childhood cancer
cases, conducting any epidemiological surveillance is often
challenging, especially for LMICs. For these countries,
where approximately 83 % of the world population is
living, very limited basic epidemiological information is
available [1]. The lack of basic epidemiological informa-
tion on childhood malignancies hinders the understanding
of the spectrum of childhood malignancies and also the
efforts to set up cancer control strategies, to improve
cancer care and the clinical outcomes for affected children
in these countries.
In Bangladesh, the overall cancer burden including
adolescent and childhood cancer is largely unknown due
to the nonexistence of (population-based) cancer registries
[3, 4]. The proportion of childhood cancers is expected to
be high in Bangladesh because of the young population
structure- about 30 % (47.4 million) of the population is
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under 15 years old [5]. Based on the estimated childhood
cancer incidence (<15 years) of LMICs and India (102 and
124 per million person-years respectively), 5500–6700
new cases are expected each year [6, 7]. The number of
pediatric cancer cases are expected to increase since
Bangladesh has significantly reduced the childhood
mortality rate by 71 % compared to 1990s due to better
management of infectious diseases [8]. For the whole
country there are only four main public hospitals (two
recently introduced), which are specialized in pediatric
oncology. The overall healthcare system including cancer
diagnosis, treatment and management encounters severe
shortage of infrastructure and trained health manpower
[3]. Approximately 500 hospital beds are currently dedi-
cated for cancer patients (both adult and children) in
Bangladesh [9] and only fifteen trained pediatric hematol-
ogists/oncologists for dealing with pediatric cancers [per-
sonal communication]. This study aims to provide a
comprehensive recent overview on childhood and adoles-
cent cancers in Bangladesh, which would contribute to
the understanding of epidemiologic characteristics and
provide a basis for the future strategies to deal with child-
hood and adolescent cancers.
Methods
Data on malignant neoplasms in patients aged less than
20 years old diagnosed between 2001 and 2014 in
Bangladesh were collected by the National Institute of
Cancer Research and Hospital (NICRH) and the ASHIC
(A shelter for helpless ill children), a Foundation for child-
hood cancer. Note that, the ASHIC Foundation started
registering childhood cancer cases since 2001. The
pediatric oncology department of the NICRH was intro-
duced in 2008. Before that, childhood cancer patients were
treated under medical oncology department at NICRH as
well as other public and private hospitals. The ASHIC
Foundation is a non-governmental organization whose
purpose is to support childhood cancer patients and their
families in Bangladesh. They provide housing during treat-
ment, follow-ups in Dhaka city, palliative care service and
psychological counselling support [10]. This support is
very important because most parents face immense diffi-
culties when their child is diagnosed with cancer. For
instance, these include travel costs, managing accommo-
dation in Dhaka city and high treatment costs. The
ASHIC Foundation also registers childhood cancer cases
for specialized tertiary level hospitals outside of Dhaka
city. It is important to mention here that Bangladesh is a
lower middle-income country with a population of over
160 million [5], where approximately 72 % of the citizens
live in the resource-limited areas, but cancer care facilities
are located in the big cities, mostly in Dhaka, the capital.
There is no organized referral system in Bangladesh. Gen-
erally local practitioners suggest the parents to bring their
children to the specialized centre for better treatment.
However, in most cases, parents decide themselves to con-
sult with the experts of the specialized centres when local
practitioners could not manage the patients properly.
Clinical observations and histological examinations
were the basis of diagnosis for all collected cancer cases.
Blood counts, peripheral blood films and bone marrow
aspiration were used for the morphological diagnosis of
leukaemia. Lymph node biopsies were used to diagnose
lymphomas. Fine needle aspiration cytology or tissue
biopsies were used for solid tumours. All cases were
categorized according to the International Classification
of Childhood Cancer (ICCC) [11]. Results were provided
for all neoplasms combined as well for the main 12
ICCC diagnostic groups and the belonging subgroups
for two age groups (0–14 and 15–19 years). The whole
study period was divided into three time periods based on
the number of collected cases: 2001–2006, 2007–2010,
and 2011–2014.
Data quality
Due to the lack of systematic and effective recording
systems of medical records in public hospitals, dupli-
cated and re-enrolled cases were highly expected. A
patient might have visited the same hospital or different
hospitals several times. Such duplicates were excluded
for the analysis based on the following variables: name,
gender, age at admission, year of first admission, type of
cancer diagnosed and geographic location in Bangladesh
(e.g., home district of the patient). Out of 3778 cases
collected, 635 cases were duplicates (16.8 % of all
collected cases). In the final dataset, 3143 cases were
included where NIRCH and ASHIC Foundation contrib-
uted1,690 and 1453 cases respectively. Patients regis-
tered by the ASHIC Foundation were diagnosed in 20
different tertiary hospitals mostly located in Dhaka,
except two hospitals outside of Dhaka city. Most cases
(72 %) were derived from the two main specialized
pediatric oncology centres in Dhaka (Fig. 1) and were
mainly diagnosed in children aged under 15 years
(93 %). Data cleaning and validation were performed by
seven researchers, two pediatric oncologists, one epi-
demiologist and one statistician. The study protocol was
ethically approved by the Ethical Review Committee
(ERC) of National Institute of Cancer Research and
Hospital (this is the only state-run specialized cancer
hospital in Bangladesh) under the official memo no.
NICRH/Ethics/2013/104. Our retrospective study was
based on medical record and therefore, the issue of in-
formed consent was waived by ERC of NICRH.
Statistical analyses
Distribution of the 12 main ICCC diagnostic groups was
given for the three study periods. In case of adolescent
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cancers, data was available from 2007. Because of this
limitation, we considered 2001–2006 as the first time
period for children and continued with two subsequent
equal time periods (2007–2010 and 2011–2014) for
childhood and adolescent cancers. The incidence rates
were calculated as the average annual number of cases
per million person-years [12]. For the population at risk
the average of estimated population numbers from 2000
to 2005 was taken for the first study period 2001–2006,
2005 and 2010 for 2007–2010, and 2010 and 2015 for
the last study period 2011-2014 [5]. Weights of the
World standard population were used to calculate age-
standardised rates (ASR) for the age group 0–14 years,
and age-specific rates (Rate) were given for the age
group 15–19 years. Analyses were performed using SAS
software (SAS system 9.2, SAS Institute, Cary, NC).
Results
A total of 3,143childhood and adolescent cancer cases
were collected over the study period of 2001–2014 for
this retrospective study. The average number of col-
lected cases per year varied from 76 in 2001–2006 to
247 in 2007–2010 and 369 in 2011–2014. The age-
standardised incidence rate was 7.8 per million children
and 2.1 per million adolescents (Table 1) in 2011–2014.
The sex ratio (M: F) declined from 2.5 in 2001–2006 to
2.1 in 2007–2010 and 1.9 in 2011–2014. During the first
period approximately 80 % of the childhood cancer cases
were leukaemias and lymphomas, while this was 51 % in
2007–2011 and about 25 % in 2011–2014. Other large
changes in time were observed for retinoblastoma,
malignant bone tumours, and germ cell and gonodal tu-
mours (Table 1). In the latest period, the most common
cancer types were leukaemia, retinoblastoma and malig-
nant bone tumours. Acute lymphoblastic leukaemia (ALL)
was by far the most common type of leukaemia (86 %).
Half of all malignant bone tumours were osteosarcomas
while 45 % was Ewing tumours. Lymphomas were the fifth
most prevalent type of childhood cancer, where the pro-
portion of non-Hodgkin lymphoma (59 %) was higher
than Hodgkin lymphoma (19 %). One fourth of the epithe-
lial tumours were nasopharyngeal carcinomas.
Most common cancer types among adolescents were
lymphomas, malignant bone tumours and germ cell
and gonadal tumours in 2007–2010. Largest shifts in
2011–2014 were observed for lymphomas (−82 %),
CNS tumours (+900 %) and malignant bone tumours
(+178 %), which led to the following top three most
common cancer types: malignant bone tumours, germ
cell and gonadal tumours, and epithelial tumours
(Table 2). Osteosarcomas were the most prevalent
malignant bone tumour (68 %). In contrast to the chil-
dren, nasopharyngeal carcinomas were less common
among adolescents while three patients were surpris-
ingly diagnosed with retinoblastoma at 15–19 years age
group.
The lowest median age at diagnosis was 3 years for
retinoblastoma, renal tumours and hepatic tumours, while
12 years for malignant bone tumours. Retinoblastoma
(83 %), nephroblastoma (67 %) and neuroblastoma (57 %)
predominantly occurred among children aged 0–4 years
(Fig. 2). Bone tumours (87 %), germ cell and gonadal tu-
mours (44 %), and other epithelial tumours (64 %) were
frequently observed among the older age groups (10–19
years). Leukaemias were mostly diagnosed in children
aged 5–9 years (41 %). The same pattern was also ob-
served forALL whileacute myeloid leukaemia (AML) was
more common among children aged 10–14 years (45 %).
Discussion
Best of our knowledge, this is the first epidemiological study
that provides an overview on childhood and adolescent
cancer in Bangladesh. Retinoblastoma and leukaemias were
the most common childhood cancers while malignant bone
Fig. 1 Distribution of recorded cases by hospitals, 2001–2014
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tumours, germ cell and gonadal tumours, and epithelial
tumours were more common among adolescents. In con-
trast, a single-hospital based study (n = 1250) showed that
lymphoma was the most common childhood cancer in
Bangladesh [13], while another study reported nephroblas-
toma/Wilmstumour being the most frequent pediatric
malignancy (n = 70) [14]. However, the strength of this
particular study is that it has collected cases from 20
different tertiary hospitals and therefore, this study pro-
vides a better representation of the overall scenario of
childhood cancers in Bangladesh.
Over time, the childhood and adolescent cancer inci-
dence has increased which is most likely due to improved
awareness among clinicians, diagnostics and registration.
Hence, the most recent period (2011–2014) represents the
most reliable overview although the incidence rates are
still low compared to India where the total childhood
cancer rates varied between 38 and 124 per million
person-years compared to 8 per million person-years in
Bangladesh [6]. Underreporting of malignancies is well-
known in resource-limited countries. Apart from inad-
equate access to health care, lack of professional educa-
tion, infrastructure (such as advanced diagnostic facilities
and imaging devices) and low level of health awareness as
well as various socioeconomic factors that lead to the
under-representation of cancer incidence; the presenting
symptoms for some pediatric cancers (especially leukae-
mias) resemble with those of infections. Collecting
epidemiological data wasalso encountered with huge diffi-
culties due to lack of an adequate record keeping system
Table 1 Childhood cancer incidence (0–14 years) by period of diagnosis in Bangladesh, 2001–2014
Period of diagnosis
2001–2006 2007–2010 2011–2014
ICCC diagnostic group N % ASRa N % ASRa N % ASRa M:F ratio
Total 455 2.0 988 5.1 1474 7.8 2.0:1
I Leukaemia 269 59.1 1.2 264 26.7 1.4 271 18.4 1.4 3.2:1
ALL 226 212 234
AML 18 38 29
II Lymphoma 89 19.6 0.4 237 24.0 1.2 115 7.8 0.6 2.7:1
Hodgkin lymphoma 7 74 22
Non-Hodgkin lymphoma 31 121 68
III CNS tumours – – – 5 0.5 0.03 65 4.4 0.3 1.5:1
Ependymoma – – 15
Astrocytoma – – 16
Medulloblastoma – – 16
IV Neuroblastoma 17 3.7 0.08 24 2.4 0.1 54 3.7 0.3 1.0:1
V Retinoblastoma 6 1.3 0.03 74 7.5 0.4 374 25.4 2.1 1.8:1
VI Renal tumours 27 5.9 0.2 95 9.6 0.5 90 6.1 0.5 2.1:1
Nephroblastoma 25 87 89
VII Hepatic tumours 8 1.8 0.04 13 1.3 0.07 29 2.0 0.2 3.8:1
Hepatoblastoma 8 13 29
VIII Bone tumours 2 0.4 0.01 60 6.1 0.3 175 11.9 0.9 1.6:1
Osteosarcoma 1 38 91
Chondrosarcoma – – 4
Ewing tumour 1 22 79
IX Soft tissue sarcomas 18 4.0 0.09 45 4.6 0.2 101 6.9 0.5 2.0:1
Rhabdomyosarcoma 18 34 74
Fibrosarcoma – 3 14
X Germ cell and gonadal tumours 7 1.5 0.03 117 11.8 0.6 125 8.5 0.6 1.2:1
XI Other epithelial tumours 3 0.7 0.01 36 3.6 0.2 52 3.5 0.3 2.7:1
Nasopharyngeal carcinoma 1 18 13
XII Other and unspecified tumours 9 2.0 0.04 18 1.8 0.09 23 1.6 0.1 1.6:1
aASR: Age standardised rate per 1 million person-years (World Standard Population)
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in public hospitals, for which it was not possible to study
e.g., treatment outcomes and survival.
Sex-specific differences in the incidence of pediatric
malignancies are consistent globally. Male predominance
is a common phenomenon for many childhood cancers.
In developed countries, the sex ratio of boys to girls is
about 1.1 ~ 1.34 [15], where some cancers including
nephroblastoma and retinoblastoma generally exhibit
slightly female preponderance [16]. The overall propor-
tion of cancers was much higher in males than females
in Bangladesh. For some cancers (leukaemias and hepa-
toblastoma), the male predominance was noted to be
more than three times higher among Bangladeshi boys,
while the sex ratio was almost equal for neuroblastoma,
and germ cell and gonadal tumours.
This retrospective study revealed that retinoblastoma
was the most frequent (25 %) childhood cancer in
Bangladesh in 2011–2014. The numbers of retinoblastoma
patients are generally higher in developing countries as
they have high birth rates, such as in Asia and Africa [17].
Most cases (83 %) occurred in children younger than
5 years old (Fig. 2) with a median age of 3 years. Even
though it is generally very uncommon after the age of 10,
we have noted that about 3 % of all retinoblastoma cases
were aged between 10 and 19 years. This could be due to
a delayed diagnosis, which is common in developing
countries [18, 19]. Retinoblastoma is a curable tumour in
more than 90 % of cases, if it is detected at early stages
[20]. As compared to other malignancies, the early signs
of retinoblastoma are easily detectable if healthcare
Table 2 Adolescent cancer incidence (15–19 years) by period of diagnosis in Bangladesh, 2001–2014
Period of diagnosis
2007–2010 2011–2014
ICCC diagnostic group N % Ratea N % Ratea M:F ratio
Total 93 1.5 133 2.1 1.4:1
I Leukaemia 3 3.2 0.05 6 4.5 0.09 5.0:1
ALL 2 6
AML 1 –
II Lymphoma 38 40.9 0.6 7 5.3 0.1 1.3:1
Hodgkin lymphoma 13 2
Non-Hodgkin lymphoma 25 4
III CNS tumours 1 1.1 0.02 10 7.5 0.2 2.3:1
Ependymoma – –
Astrocytoma – 3
Medulloblastoma – 5
IV Neuroblastoma – – – – – – –
V Retinoblastoma 1 1.1 0.02 2 1.5 0.03 –
VI Renal tumours 3 3.2 0.05 – – – –
Nephroblastoma 3 –
VII Hepatic tumours – – – 1 0.8 0.02 –
Hepatoblastoma – 1
VIII Bone tumours 18 19.4 0.3 50 37.6 0.8 1.9:1
Osteosarcoma 13 34
Chondrosarcoma – 1
Ewing tumour 5 15
IX Soft tissue sarcomas 6 6.5 0.1 11 8.3 0.2 0.6:1
Rhabdomyosarcoma 5 6
Fibrosarcoma – 2
X Germ cell and gonadal tumours 14 15.1 0.2 22 16.5 0.4 0.4:1
XI Other epithelial tumours 7 7.5 0.1 21 15.8 0.3 4.3:1
Nasopharyngeal carcinoma 4 1
XII Other and unspecified tumours 2 2.2 0.03 3 2.3 0.05 0.5:1
aRate: Age-specific rate per 1 million person-years
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professionals as well as parents are aware of this malig-
nant disease. A retinoblastoma education programme in
Honduras has shown to reduce the proportion of ad-
vanced stages significantly. However, it was not successful
in improving treatment compliance [21].
Leukaemias were the second most common childhood
malignancy (18 %) in Bangladesh in 2011–2014. However,
during the whole study period (2001–2014), leukaemias
constituted most cases (28 %). The proportion of leukae-
mias varies across different countries ranging from 27 to
35 % [6, 15, 21, 22]. In US, for instance, leukaemias
account for 31 % of all pediatric cancers, while it is
approximately 37 % in Kolkata, a neighboring Indian state
and nearly 26 % in Pakistan with similar culture and socio-
economic structures to Bangladesh [22, 23]. ALL com-
prised of the major proportion (84 %) of childhood
leukaemia (Table 1) between 2001 and 2014. As men-
tioned earlier about under-reporting, a recent population-
based study has shown that nearly 15–35 % of ALL cases
go unreported [24]. Reasonably, taking all these issues
together, the proportion of leukaemias would be signifi-
cantly much higher in Bangladesh than our present find-
ings. The presenting mean age of leukaemia patients in
South Asian countries (Bangladesh, India and Pakistan)
was found to be higher (6–7 years) than those of Western
countries where incidence peak was between 0 and 4 years
[16, 25–27]. Interestingly, the similar age distribution of
leukaemia was also noted among South Asian population
in UK [28].
In high-income countries, brain/CNS tumours are the
second most pediatric cancer comprising 20–27 % of all
cases, whereas lymphomas are the distant third childhood
malignancy [16, 29–31]. However, it has been found that
lymphomas were the fifth most frequently diagnosed cancer
(7.8 %) in Bangladeshi children and CNS tumours were
even more less common (4.4 %), ranked eighthamong of all
childhood cancers. Very low incidence rates of CNS
tumours in low-income countries including Bangladesh is
likely associated with the lack of modern diagnostic facil-
ities [7]. In cases of lymphomas, a similar pattern was also
Fig. 2 Pattern of age at diagnosis of selected childhood and adolescent cancers in Bangladesh, 2001–2014
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noted in India and Pakistan but the pattern of NHL and
HD was opposite to this study [6, 22]. We observed that
there was a higher proportion of NHL (about 70 %) in
comparison to HD, a pattern similar to developed world.
The age distribution was similar for NHL and HD; about
80 % of lymphoma cases were diagnosed in children aged
5–14 years with a median age between 7 and 8 years [Fig. 2].
However, HD is usually rare among children younger than
10 years, but one of the most common cancers among ado-
lescents (15–19 years) in industrialized countries [16, 32].
Malignant bone tumours were the most common type
of cancer among adolescents and ranked third among
childhood cancer with a median age of 12 years. Osteo-
sarcoma (58 %) and Ewing sarcoma (40 %) were the two
most common types of malignant bone cancers. The
age-specific distribution pattern of osteosarcoma and
Ewing sarcoma showed that they were rare before the
age of five years and the proportion increased with ages
throughout childhood; both peaked at the ages of 10 to
13 years. This age pattern resembles with that of devel-
oped countries [16].
Conclusion
This is the first study which provides an overview on the
distribution of pediatric cancers in Bangladesh. Incidences
are lower than expected most likely due to a low level of
awareness regarding cancer among clinicians and the popu-
lation, inadequate access to health care, lack of diagnostic
equipment and incomplete recording of cases. Improve-
ments on different levels(e.g., training more pediatricians
about symptoms of childhood and adolescent cancer, avail-
ability of diagnostic equipment, good documentation of
medical information in hospitals) should be implemented
to get a better insight into the size of this ‘health problem’
and to detect cancer earlier, which will subsequently result
in a better outcome for affected children and adolescents.
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